CNBC December 24, 2024
Ashley Capoot

Key Points

– It’s been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath.

– According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.

– “The pandemic was a huge pull forward in demand, and we’re facing those tough, challenging comps,” said Scott Schoenhaus, an analyst at KeyBanc Capital Markets.

If the Covid era marked a boom time for digital health companies, 2024 was the reckoning.

In a year that saw the Nasdaq jump 32%, surpassing 20,000 for the first time this month, health tech providers largely suffered. Of 39 public digital health...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Investments, Technology, Trends
The Responsibility of Innovation: Collaboration, Trust, and the Real Superheroes of ViVE 2025
Virtual Care Platforms Experience Unprecedented Growth, Ushering in the Next Era of Hybrid Healthcare, Reports Black Book Research
Yhprum's Law applied to Healthcare Technology: Celebrate the unexpected victories because "Everything that can work, will work"
5 Notable Health Tech Funding Announcements in February
HIMSS 2025: Four big themes of the health conference

Share This Article